Invest3 publishersIndependently confirmed3 min readPublished
Jacob Coxon's exit from Anthropic tests a $2 trillion IPO pitched on safety
Anthropic researcher Jacob Coxon quit the AI industry in public on September 8, as the company seeks a $2 trillion valuation for its IPO. The governance risk investors can price sits with leaders who back slowing the industry.
The Investor · Invest desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction
What happened
- Coxon said former colleagues at OpenAI and Anthropic "earnestly believe that it could kill us all by the end of the decade" and that the labs are "gambling with our lives."
- Within days, leaders of rival labs agreed, in a rare show of unity, that it is time to slow the industry's accelerating development.
- Coxon, Amodei and OpenAI chief scientist Jakub Pachocki were among more than 1,000 researchers who signed a statement urging governments to coordinate a brake on self-improving models.
- Sen. Bernie Sanders and Rep. Greg Casar introduced a bill to permanently ban superintelligence and pause model development until a regulator sets rules.
Compiled by The InvestorSomething wrong?How this is made
Why it matters
- exposure Buyers of an Anthropic offering near $2 trillion would fund growth its own leaders have urged the industry to slow, and the risk factors will have to explain how the company holds both positions.
- precedent A public exit with no rival job and no retained stake makes dissent cheaper for the next researcher who wants to speak, because neither a new employer nor old equity is on the line.
- contradiction If the boosters are right that the safety push serves rules favoring the largest labs, the same exit that clouds Anthropic's growth case strengthens its position as an incumbent.
Daniel Kokotajlo, who resigned from OpenAI in 2024, recalls a researcher telling him that quitting a lab was akin to "renouncing your citizenship. Now you're a nobody. Who is going to protect you?" [16] The usual answer is the rival lab. According to New York Magazine, people who leave one lab often go straight to another [15]. Coxon took that route once. He spent about three years in pretraining roles at OpenAI [8], then moved to Anthropic earlier this year because of its reputation for model safety [5]. His second exit came less than nine months later [24]. This time he is leaving the industry [7], and he holds no ongoing financial stake in Anthropic [17].
Staff retention is where the case for a discount is weakest. To Vima's report calls Coxon's exit one of the first cases of an Anthropic employee leaving over safety fears. The only other one it cites from this year is a safety researcher who left to study poetry, warning that "the world is in peril" [9]. The same outlet describes Coxon as one of hundreds of researchers just like him across Silicon Valley's AI companies [18]. Two departures against that population do not make an attrition rate. The reports do not include headcount or turnover figures, so a retention discount on Anthropic cannot be sized.
The governance exposure an investor can price is at the top. Anthropic is seeking a $2 trillion valuation in an IPO expected to rank among the largest ever, and it has emphasized responsible development when courting investors [19]. Amodei and other company leaders have repeatedly urged the industry to slow development [14]. Amodei said he agreed with Coxon more than he disagreed with him [11]. Coxon's timeline is short. "We're on track for a lot of the most aggressive of these scenarios where by the end of next year things could be out of control already," he said [25]. He added that safety trade-offs are inevitable when labs compete with one another and with Chinese upstarts [6]. Anthropic did not immediately comment on the departure [22].
In one outcome, the slowdown becomes binding and coordinated, and growth slows with it. According to To Vima, AI boosters see Coxon's exit as part of a coordinated push for global regulations favorable to the biggest companies [20]. In another, the slowdown stays talk. There are no federal AI regulations, and the administration prefers a light touch [13]. President Trump said a "strong and smart" president is the only guardrail needed, and China dismissed the concerns as "fearmongering" [12]. In a third, more researchers follow Coxon out before the listing, and the retention problem the record does not yet show becomes one the prospectus has to disclose.
I think the second outcome is the likeliest in the near term, given Washington's posture. If it holds, Coxon's exit changes Anthropic's risk disclosures more than its business. The case against that view is the first outcome, where lab leaders who have already agreed to slow down turn the agreement into rules. The retention thesis would be proved right by further public exits from Anthropic's capabilities teams before the IPO, or by turnover figures in the filing.
What to watch
- Coxon's testimony at the New York City Council AI safety hearing on October 5, 2026, and whether the Anthropic, OpenAI, Google and Meta leaders appearing there commit to specific limits.
- Whether the slowdown rival lab leaders agreed to becomes a written, dated commitment or a government-run brake of the kind the 1,000-researcher statement asks for.